Stenting and cell technologies in the treatment of atherosclerotic renovascular hypertension Part 1. Effectiveness and safety of renal artery stenting in ischemic kidney disease
Aim. To assess renal artery stenting (RAS) effectiveness and safety in patients with renovascular hypertension (RVH) duration over 10 years.Material and methods. Seventy-eight patients were randomized into main (n=26) and placebo groups (n=52). Primary end-point was systolic blood pressure (SBP) lev...
Main Authors: | A. N. Kharlamov, Ya. L. Gabinsky, M. S. Freydlina, E. K. Bos, T. A. Naydanova, S. D. Chernyshev, B. V. Fadin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1561 |
Similar Items
-
Stenting and cell technologies in the treatment of atherosclerotic renovascular hypertension Part 2. Effectiveness and safety of postnatal
by: Ya. L. Gabinsky, et al.
Published: (2008-10-01) -
Stenting and cell technologies in the treatment of atherosclerotic renovascular hypertension Part 3. Some genetic, pharmacological, and radio-ecological features of malignant renovascular hypertension
by: A. N. Kharlamov, et al.
Published: (2008-12-01) -
Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01) -
Factors affecting the effectiveness of endovascular kidney revascularization in patients with renal arteria stenosis
by: E. V. Frolova, et al.
Published: (2020-12-01) -
EXPERIENCE OF ABSORB SCAFFOLDS APPLICATION IN THE DEPARTMENT OF ROENTGEN-ENDOVASCULAR DIAGNOSTICS AND TREATMENT OF BASHKORTOSTAN STATE MEDICAL UNIVERSITY CLINIC
by: V. V. Plechev, et al.
Published: (2017-01-01)